Table 21:
Scenario Analysis 3—Parameter Inputs for All-Cause Mortality Effects
| Intervention:Comparator | Relative Mortality Estimate | Standard Error | Source |
|---|---|---|---|
| LAAC device:warfarin | 0.71 | 0.1865 | Holmes et al, 201420; Reddy et al, 201440 |
| Apixaban:warfarin | 0.91 | 0.0682 | Granger et al, 201116 |
| Dabigatran 110 mg:warfarin | 0.88 | 0.0685 | Connolly et al, 200915 |
| Dabigatran 150 mg:warfarin | 0.89 | 0.0582 | Connolly et al, 200915 |
| Rivaroxaban:warfarin | 0.83 | 0.0954 | Patel et al, 201117 |
Abbreviation: LAAC device, left atrial appendage closure device with delivery system.